Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs).

Early on, intriguing biological activities were found associated with the EETs using in vitro systems. Although the EETs other than the 5,6-isomer, are quite stable chemically, they are quickly degraded enzymatically with the sEH accounting in many cases for much of the metabolism. This rapid degradation often made it difficult to associate biological effects with the administration of EETs and other lipid epoxides particularly in vivo. Thus, it is the power to inhibit the sEH that has facilitated the demonstration of many physiological processes associated with EETs and possibly other epoxy fatty acids. In the last few years it has become clear that major roles of the EETs include modulation of blood pressure and modulation of inflammatory cascades. There are a number of other physiological functions now associated with the EETs including angiogenesis, neurohormone release, cell proliferation, G protein signaling, modulation of ion channel activity, and a variety of effects associated with modulation of NFkappaB. More recently we observed a role of the EETs as modulated by sEHI in reducing non-neuropathic pain. The array of biological effects observed with sEHI illustrates the power of modulating the degradation of chemical mediators in addition to the modulation of their biosynthesis, receptor binding and signal transduction. Many of these biological effects can be modulated by sEHIs but also by the natural eicosanoids and their mimics all of which offer therapeutic potential.

[1]  B. Hammock,et al.  The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Kluger,et al.  Role of cytochrome P-450 in endogenous antipyresis. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[3]  B. Hammock,et al.  Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain. , 2006, Life sciences.

[4]  J. Mcgiff,et al.  Cytochrome P-450 metabolism of arachidonic acid. , 1991, Annual review of pharmacology and toxicology.

[5]  A. Hohmann,et al.  Selective activation of cannabinoid CB2 receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation , 2003, Neuroscience.

[6]  D. Cockayne,et al.  Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  B. Borhan,et al.  Mechanism of Soluble Epoxide Hydrolase , 1995, The Journal of Biological Chemistry.

[8]  A. Basbaum,et al.  Molecular mechanisms of nociception , 2001, Nature.

[9]  B D Hammock,et al.  Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids , 2000, Circulation research.

[10]  B. Hammock,et al.  Toxicity of epoxy fatty acids and related compounds to cells expressing human soluble epoxide hydrolase. , 2000, Chemical research in toxicology.

[11]  A. Hohmann,et al.  Selective Activation of Cannabinoid CB2 Receptors Suppresses Hyperalgesia Evoked by Intradermal Capsaicin , 2004, Journal of Pharmacology and Experimental Therapeutics.

[12]  F. Oesch,et al.  The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Molleman,et al.  Cannabinoid signalling (review) , 2006 .

[14]  B. Hammock,et al.  An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive Hypertension , 2005, Hypertension.

[15]  J. Casida,et al.  Mammalian metabolism and environmental degradation of the juvenoid 1-(4'-ethylphenoxy)-3,7-dimethyl-6,7-epoxy-trans-2-octene and related compounds. , 1974, Journal of agricultural and food chemistry.

[16]  B. Borhan,et al.  Improved radiolabeled substrates for soluble epoxide hydrolase. , 1995, Analytical biochemistry.

[17]  B. Hammock,et al.  Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. , 2005, Annual review of pharmacology and toxicology.

[18]  B. Hammock,et al.  Soluble epoxide hydrolase is a therapeutic target for acute inflammation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  B. Hammock,et al.  Soluble Epoxide Hydrolase Inhibition Lowers Arterial Blood Pressure in Angiotensin II Hypertension , 2002, Hypertension.

[20]  B. Hammock,et al.  Membrane-bound and soluble-fraction epoxide hydrolases: methodological aspects , 1985 .

[21]  J. Willer,et al.  Hyperalgesia and allodynia: peripheral mechanisms. , 2005, Joint, bone, spine : revue du rhumatisme.

[22]  B. Hammock,et al.  Hydration of cis- and trans-epoxymethyl stearates by the cytosolic epoxide hydrase of mouse liver. , 1979, Biochemical and biophysical research communications.

[23]  R. Estabrook,et al.  The reaction of arachidonic acid epoxides (epoxyeicosatrienoic acids) with a cytosolic epoxide hydrolase. , 1983, Archives of biochemistry and biophysics.

[24]  B. Hammock,et al.  Epoxide hydrolases: their roles and interactions with lipid metabolism. , 2005, Progress in lipid research.

[25]  B. Hammock,et al.  Metabolism of monoepoxides of methyl linoleate: bioactivation and detoxification. , 2000, Archives of biochemistry and biophysics.

[26]  J. Iliff,et al.  Soluble Epoxide Hydrolase Gene Deletion Is Protective Against Experimental Cerebral Ischemia , 2008, Stroke.

[27]  M. Fornage,et al.  The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke. , 2005, Human molecular genetics.

[28]  K. Ley,et al.  Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. , 1999, Science.

[29]  B. Hammock,et al.  Optimized thiol derivatizing reagent for the mass spectral analysis of disubstituted epoxy fatty acids. , 2001, Journal of chromatography. A.

[30]  Bruce D Hammock,et al.  Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis. , 2004, Biochemistry.

[31]  B D Hammock,et al.  Binding of Alkylurea Inhibitors to Epoxide Hydrolase Implicates Active Site Tyrosines in Substrate Activation* , 2000, The Journal of Biological Chemistry.

[32]  B. Hammock,et al.  The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS DOI 10.1194/jlr.D200018-JLR200 , 2002, Journal of Lipid Research.

[33]  B. Hammock,et al.  cDNA cloning and expression of a soluble epoxide hydrolase from human liver. , 1993, Archives of biochemistry and biophysics.

[34]  B. Borhan,et al.  Molecular and Biochemical Evidence for the Involvement of the Asp-333–His-523 Pair in the Catalytic Mechanism of Soluble Epoxide Hydrolase (*) , 1995, The Journal of Biological Chemistry.

[35]  J. Meijer,et al.  Structural characterization of the human soluble epoxide hydrolase gene (EPHX2). , 1996, Biochemical and biophysical research communications.

[36]  T. Vanderah,et al.  Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2 Cannabinoid Receptors , 2003, Anesthesiology.

[37]  T. Vanderah,et al.  CB2 cannabinoid receptor-mediated peripheral antinociception , 2001, Pain.

[38]  F. Oesch,et al.  An impaired peroxisomal targeting sequence leading to an unusual bicompartmental distribution of cytosolic epoxide hydrolase , 1991, FEBS letters.

[39]  B. Hammock,et al.  Distribution and properties of a mammalian soluble epoxide hydrase. , 1980, Biochemical pharmacology.

[40]  D. Christianson,et al.  Detoxification of environmental mutagens and carcinogens: structure, mechanism, and evolution of liver epoxide hydrolase. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Molleman,et al.  Cannabinoid signalling. , 2006, Life sciences.

[42]  L. Gilbert,et al.  Soluble mammalian epoxide hydratase: action on juvenile hormone and other terpenoid epoxides. , 1976, Comparative biochemistry and physiology. B, Comparative biochemistry.

[43]  B D Hammock,et al.  Potent urea and carbamate inhibitors of soluble epoxide hydrolases. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Xiang Fang,et al.  Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. , 2004, Progress in lipid research.